Mar Bellido

8PUBLICATIONS
59CO-AUTHORS
Foetal development and medicineOral and maxillofacial surgeryCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursDental therapeutics, pharmacology and toxicology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 24, 2026
Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancy.

|Nov 05, 2025
Effect of ruxolitinib on the oral mucosa in steroid-refractory graft-versus-host disease: a prospective observational exploratory study.

Mar Bellido, Ana-Mae E Jonk, Martina Kaurinovic

|Apr 18, 2025
Long-term follow-up of MRD-guided ibrutinib plus venetoclax in relapsed CLL: phase 2 VISION/HO141 trial.

Carsten U Niemann, Julie Dubois, Kazem Nasserinejad

|Apr 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.

Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis

|Jan 08, 2024
Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study.

Marco Herling, Claire Dearden, Francesco Zaja

|Feb 16, 2022
Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvement.

Martina Kaurinovic, Konstantina Delli, Ana-Mae E Jonk

Pageof 2

Frequent Collaborators

2 joint publications

Arjan Vissink

2 joint publications

Bart J Biemond

2 joint publications

Walter J F M van der Velden

2 joint publications

Konstantina Delli